Use of renal risk drugs in hospitalized patients with impaired renal function - An underestimated problem?

Nephrology Dialysis Transplantation

Volumn 21, Issue 11, 2006, Pages 3164-3171

  Blix, Hege Salvesen ^a   Viktil, Kirsten Kilvik ^a   Moger, Tron Anders ^a   Reikvam, Aasmund ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Drug related problems; Drugs; Kidney disease; Renal impairment; Renal risk drugs

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ATENOLOL; BENZODIAZEPINE DERIVATIVE; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FLUINDOSTATIN; FUROSEMIDE; GLIBENCLAMIDE; LISINOPRIL; LITHIUM; LOOP DIURETIC AGENT; METFORMIN; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PIVMECILLINAM; PRAVASTATIN; RANITIDINE; SIMVASTATIN; SPIRONOLACTONE; TRAMADOL; UNINDEXED DRUG; WARFARIN;

ADULT; AGED; ANAMNESIS; ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG USE; FEMALE; FREQUENCY ANALYSIS; GENERAL HOSPITAL; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CODING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL PROTECTION; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLOPURINOL; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYTIC AGENTS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PATIENT ADMISSION; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33750031058     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl399     Document Type: Article

References (18)

1. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
2. St Peter WL, Khan SS, Ebben JP, Pereira BJ, Collins AJ. Chronic kidney disease: The distribution of health care dollars. Kidney Int 2004; 66: 313-321
3. Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 2002; 136: 604-615
4. Turnheim K. Drug therapy in the elderly. Exp Gerontol 2004; 39: 1731-1738
5. Manian FA, Stone WJ, Alford RH. Adverse antibiotic effects associated with renal insufficiency. Rev Infect Dis 1990; 12: 236-249
6. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991; 115: 165-172
7. St Peter WL, Schoolwerth AC, McGowan T, McClellan WM. Chronic kidney disease: Issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis 2003; 41: 903-924
8. Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J 2003; 33: 10-13
9. Salomon L, Deray G, Jaudon MC et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care 2003; 15: 331-335
10. Cantu TG, Ellerbeck EF, Yun SW, Castine SD, Kornhauser DM. Drug prescribing for patients with changing renal function. Am J Hosp Pharm 1992; 49: 2944-2948
11. National Kidney Foundation K/DOQI. Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002; 39 [Suppl 1]: S1-S266
12. http://www.kidney.org/professionals/kdoqi/gfr_calculator.cfm. (accessed 24 April, 2006)
13. Norsk Legemiddelhåndbok for helsepersonell. Oslo: Foreningen for utgivelse av Norsk Legemiddelhåndbok, May 2004.
14. British National Formulary, 48th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2004
15. DRP-classification: Van Mil Consultancy, Pharmaceutical Care Network Europe, V3.01. 2002
16. Blix HS, Viktil KK, Reikvam A et al. The majority of hospitalised patients have drug-related problems: Results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004; 60: 651-658
17. Papaioannou A, Clarke JA, Campbell G, Bedard M. Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc 2000; 48: 1470-1473
18. Shlipak MG. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 2003; 138: 917-924